InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
2
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-15.9%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the complete record of transactions filed by Humphries William D., 董事. Officer active across 4 companies, notably STRATA Skin Sciences, Inc.. In total, 12 disclosures have been recorded. Split: 2 buys · 0 sell. Total volume traded: €48k. Activity tracked since 20 July 2021. The latest transaction was filed on 22 September 2023 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Humphries William D.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
11,580 股Common StockSEC:0001674278-26-000002:0
4,793 股Common StockSEC:0001415889-25-016249:0
4,660 股Common StockSEC:0001415889-24-015364:0
22,727 股@ US$0.4058.7% 占其流量Common StockSEC:0001209191-23-050381:0
36,408 股@ US$1.0341.9% 占其流量SSKN Common StockSEC:0001051514-23-000029:0
4,507 股Common StockSEC:0001209191-23-034477:0
2,538 股Common StockSEC:0001169245-23-000031:0
3,356 股Common StockSEC:0001209191-22-034585:0
16,950 股@ US$1.733632.4% 占其流量SSKN Common StockSEC:0001051514-22-000035:0
标准退出：2022年6月23日 (T+90)
14,783 股@ US$1.58225.8% 占其流量SSKN Common StockSEC:0001051514-22-000033:0
标准退出：2022年6月22日 (T+90)
22,727 股@ US$0.1526.0% 占其流量Common StockSEC:0001209191-22-002893:0
20,000 股0SSKN Common StockSEC:0001051514-21-000034:0
12 条申报中的 12 条
About Humphries William D.
Humphries William D. is Administrateur at Aclaris Therapeutics, Inc., STRATA Skin Sciences, Inc., Clearside Biomedical, Inc. and PhaseBio Pharmaceuticals Inc. He has 12 filings in total, and across the 12 recent filings tracked, buy transactions total 47938 EUR and sell transactions total 0 EUR, with the most common transaction nature listed as Levée d'options, over the period from 2021-07-21 to 2026-06-08.
